SteelPeak Wealth’s Astrana Health ASTH Stock Holding History
Bought
Maintained
Sold
Other funds holding ASTH
3C
SteelPeak Wealth's ASTH Position: Q2 2026 in Review
SteelPeak Wealth reduced its Astrana Health (ASTH) stake by 17% in Q2 2026, selling an estimated $3.42M and leaving 464,937 shares worth $21.6M. The position accounts for 0.56% of the portfolio, ranked #39.
SteelPeak Wealth first reported a position in ASTH in Q4 2021 and has held it in 19 quarters since. The position peaked at $39.4M in Q3 2024. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.
- SteelPeak Wealth held 464,937 shares of Astrana Health worth $21.6M as of Q2 2026.
- SteelPeak Wealth sold 95,000 Astrana Health shares in Q2 2026, an estimated $3.42M.
- Astrana Health made up 0.56% of SteelPeak Wealth's portfolio in Q2 2026, its #39 holding.
- SteelPeak Wealth first reported a position in Astrana Health in Q4 2021 and has held it in 19 quarters since.
- SteelPeak Wealth's Astrana Health position peaked at $39.4M in Q3 2024.
- 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.
Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.